$FEAM Balance Sheet | Understand Stock

$FEAM

$2.41 +$0.12 (5.23%) Pre-market

$FEAM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2026 As of Jun 30, 2026	Q3 FY2026 As of Mar 31, 2026	Q2 FY2026 As of Dec 31, 2025	Q1 FY2026 As of Sep 30, 2025	Q4 FY2025 As of Jun 30, 2025	Q3 FY2025 As of Mar 31, 2025	Q2 FY2025 As of Dec 31, 2024	Q1 FY2025 As of Sep 30, 2024	Q4 FY2024 As of Jun 30, 2024	Q3 FY2024 As of Mar 31, 2024	Q2 FY2024 As of Dec 31, 2023	Q1 FY2024 As of Sep 30, 2023	Q4 FY2023 As of Jun 30, 2023	Q3 FY2023 As of Mar 31, 2023	Q2 FY2023 As of Dec 31, 2022	Q1 FY2023 As of Sep 30, 2022	Q4 FY2022 As of Jun 30, 2022	Q3 FY2022 As of Mar 31, 2022
ASSETS
Current assets:
Cash and cash equivalents
Prepaid expenses
Deferred offering costs and other current assets
Prepaid expenses and other current assets
Total current assets
Mineral rights and properties, net
Construction in progress
Properties, plant and equipment, net
Reclamation bond deposits
Right of use asset
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities
Lease liabilities, current
Total current liabilities
Long-term debt, net
Convertible note derivative liabilities
Lease liabilities
Accrued reclamation liabilities
Asset retirement obligations
Total liabilities
Stockholders' Equity:
Preferred stock, $0.01 par value; 20,000,000 shares authorized; no shares outstanding
Common stock, $0.01 par value; 360,000 shares authorized; 41,515 and 20,018 shares outstanding June 30, 2026 and June 30, 2025, respectively
Additional paid-in capital
Reporting currency translation
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Total stockholders' equity

Total liabilities and stockholders' equity

Comments